Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916817801> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2916817801 abstract "The P latelet- O riented I nhibition in N ew T IA and minor ischemic stroke (POINT) Trial is a prospective, randomized, double-blind, multicenter international trial with the primary null hypothesis that in patients with TIA or minor ischemic stroke treated with aspirin 50-325 mg/day, there is no difference in survival free of ischemic stroke, myocardial infarction, and ischemic vascular death at 90 days in those treated with clopidogrel (600 mg loading dose then 75 mg/day) compared to placebo when therapy is initiated within 12 hours of time last known free of new ischemic symptoms. Methods: The primary endpoint is a composite outcome of new ischemic events: ischemic stroke, myocardial infarction or ischemic vascular death. Subjects are 18 years or older with high-risk TIA (ABCD 2 score ≥ 4) or minor ischemic stroke (NIHSS ≤ 3) meeting eligibility criteria who can be randomized within 12 hours of the qualifying event. Follow-up is 90 days from randomization so event rates are high throughout the period of study. A total of 5,840 patients will be recruited. The first subject was enrolled on May 28, 2010; international sites joined in August 2013. Principal Investigator: S. Claiborne Johnston, MD, PhD, The University of Texas at Austin Co-Principal Investigators: J. Donald Easton, MD, University of California, San Francisco; Anthony S. Kim, MD, MAS, University of California, San Francisco Contact: Mary Farrant, MBA, BSN, RN, University of California, San Francisco, Director, POINT Trial —UCSF Clinical Coordinating Center (CCC), San Francisco, California, 94158; Phone: 1-415-502-7304; Email: mary.farrant2@ucsf.edu Planned Number of Centers: 225; Present Number: 195 Planned Number of Subjects: 5,840; Present Number: 4,586 (June 2017) Sponsor: University of California, San Francisco (UCSF); National Institute of Neurological Disorders and Stroke (NINDS) Collaborators: Neurological Emergencies Treatment Trials Network (NETT); Statistics and Data Management Center (SDMC) at Medical University of South Carolina (MUSC); POINT Clinical Research Collaboration (POINT-CRC) at EMMES Corporation Dates of Study: October 2009 - April 2021 ClinicalTrials.gov Identifier: NCT00991029 http://clinicaltrials.gov/ct2/show/NCT00991029?term=POINT&rank=1" @default.
- W2916817801 created "2019-03-02" @default.
- W2916817801 creator A5001594817 @default.
- W2916817801 creator A5002815959 @default.
- W2916817801 creator A5003779500 @default.
- W2916817801 creator A5028929566 @default.
- W2916817801 creator A5040093844 @default.
- W2916817801 creator A5051630792 @default.
- W2916817801 creator A5059445912 @default.
- W2916817801 creator A5083340584 @default.
- W2916817801 creator A5087667863 @default.
- W2916817801 date "2018-01-22" @default.
- W2916817801 modified "2023-09-27" @default.
- W2916817801 title "Abstract WP394: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial" @default.
- W2916817801 doi "https://doi.org/10.1161/str.49.suppl_1.wp394" @default.
- W2916817801 hasPublicationYear "2018" @default.
- W2916817801 type Work @default.
- W2916817801 sameAs 2916817801 @default.
- W2916817801 citedByCount "1" @default.
- W2916817801 countsByYear W29168178012022 @default.
- W2916817801 crossrefType "journal-article" @default.
- W2916817801 hasAuthorship W2916817801A5001594817 @default.
- W2916817801 hasAuthorship W2916817801A5002815959 @default.
- W2916817801 hasAuthorship W2916817801A5003779500 @default.
- W2916817801 hasAuthorship W2916817801A5028929566 @default.
- W2916817801 hasAuthorship W2916817801A5040093844 @default.
- W2916817801 hasAuthorship W2916817801A5051630792 @default.
- W2916817801 hasAuthorship W2916817801A5059445912 @default.
- W2916817801 hasAuthorship W2916817801A5083340584 @default.
- W2916817801 hasAuthorship W2916817801A5087667863 @default.
- W2916817801 hasConcept C126322002 @default.
- W2916817801 hasConcept C127413603 @default.
- W2916817801 hasConcept C141071460 @default.
- W2916817801 hasConcept C142724271 @default.
- W2916817801 hasConcept C164705383 @default.
- W2916817801 hasConcept C168563851 @default.
- W2916817801 hasConcept C203092338 @default.
- W2916817801 hasConcept C204243189 @default.
- W2916817801 hasConcept C204787440 @default.
- W2916817801 hasConcept C27081682 @default.
- W2916817801 hasConcept C2777628954 @default.
- W2916817801 hasConcept C2777849778 @default.
- W2916817801 hasConcept C2780645631 @default.
- W2916817801 hasConcept C3020199598 @default.
- W2916817801 hasConcept C500558357 @default.
- W2916817801 hasConcept C535046627 @default.
- W2916817801 hasConcept C541997718 @default.
- W2916817801 hasConcept C71924100 @default.
- W2916817801 hasConcept C78519656 @default.
- W2916817801 hasConceptScore W2916817801C126322002 @default.
- W2916817801 hasConceptScore W2916817801C127413603 @default.
- W2916817801 hasConceptScore W2916817801C141071460 @default.
- W2916817801 hasConceptScore W2916817801C142724271 @default.
- W2916817801 hasConceptScore W2916817801C164705383 @default.
- W2916817801 hasConceptScore W2916817801C168563851 @default.
- W2916817801 hasConceptScore W2916817801C203092338 @default.
- W2916817801 hasConceptScore W2916817801C204243189 @default.
- W2916817801 hasConceptScore W2916817801C204787440 @default.
- W2916817801 hasConceptScore W2916817801C27081682 @default.
- W2916817801 hasConceptScore W2916817801C2777628954 @default.
- W2916817801 hasConceptScore W2916817801C2777849778 @default.
- W2916817801 hasConceptScore W2916817801C2780645631 @default.
- W2916817801 hasConceptScore W2916817801C3020199598 @default.
- W2916817801 hasConceptScore W2916817801C500558357 @default.
- W2916817801 hasConceptScore W2916817801C535046627 @default.
- W2916817801 hasConceptScore W2916817801C541997718 @default.
- W2916817801 hasConceptScore W2916817801C71924100 @default.
- W2916817801 hasConceptScore W2916817801C78519656 @default.
- W2916817801 hasIssue "Suppl_1" @default.
- W2916817801 hasLocation W29168178011 @default.
- W2916817801 hasOpenAccess W2916817801 @default.
- W2916817801 hasPrimaryLocation W29168178011 @default.
- W2916817801 hasRelatedWork W1584895772 @default.
- W2916817801 hasRelatedWork W1970967952 @default.
- W2916817801 hasRelatedWork W2022886132 @default.
- W2916817801 hasRelatedWork W2047171142 @default.
- W2916817801 hasRelatedWork W2073075672 @default.
- W2916817801 hasRelatedWork W2340107191 @default.
- W2916817801 hasRelatedWork W2741762255 @default.
- W2916817801 hasRelatedWork W2926542596 @default.
- W2916817801 hasRelatedWork W3000604433 @default.
- W2916817801 hasRelatedWork W4361190987 @default.
- W2916817801 hasVolume "49" @default.
- W2916817801 isParatext "false" @default.
- W2916817801 isRetracted "false" @default.
- W2916817801 magId "2916817801" @default.
- W2916817801 workType "article" @default.